Mechanisms of Immune Evasion by Tumors
The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Nguyen, L. T., Radhakrishnan, S., Ćirić, B., Tamada, K., Shin, T., Pardoll, D. M., Chen, L., Rodriguez, M., & Pease, L. R. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021466 · Cited by 105
Self-citationRetractedA genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151 · cited 1×
“…data concerning a role for CD4þCD25þ regulatory T cells in human cancer come from the recent work of Curiel et al., who showed that the presence of such regulatory T cells in ascites fluid from women with advanced ovarian cancer was associated with decreased survival (Curiel et al., 2004).”
BackgroundTumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Ishida, Y., Agata, Y., Shibahara, K., & Honjo, T. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05481.x · Cited by 3,256
Steinman, R. M., Hawiger, D., & Nussenzweig, M. C. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141040 · Cited by 3,122
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1703 · Cited by 3,085
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766 · cited 2×
“…robustly expressed on naı̈ve T cells, but is rapidly induced after T‐cell activation, and, as is the case for TGF‐b, CTLA‐4 knockout mice develop lymphoproliferative autoimmunity, indicating a tonic role for CTLA‐4—B7‐1/B7‐2 interactions in the prevention of autoimmunity (Waterhouse et al., 1995).”
BackgroundNishimura, H., Nose, M., Hiai, H., Minato, N., & Honjo, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80089-8 · Cited by 2,749 · cited 1×
“As is the case for CTLA‐4 and TGF‐b, PD1 knockout mice develop strain‐dependent autoimmune disease (Nishimura et al., 1999, 2001).”
BackgroundDong, H., Zhu, G., Tamada, K., & Chen, L. (1999) · Nature Medicine · doi:10.1038/70932 · Cited by 2,496 · cited 1×
“B7‐H1 mRNA is widely expressed, but cell surface protein is not detectable in normal tissues other than a subset of macrophages (Dong et al., 1999).”
BackgroundIKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Role of Transforming Growth Factor β in Human Disease
Blobe, G. C., Schiemann, W. P., & Lodish, H. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421807 · Cited by 2,427
T cell tolerance by clonal elimination in the thymus
Kappler, J. W., Roehm, N., & Marrack, P. (1987) · Cell · doi:10.1016/0092-8674(87)90568-x · Cited by 2,211
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Kärre, K., Ljunggren, H. G., Piontek, G., & Kiessling, R. (1986) · Nature · doi:10.1038/319675a0 · Cited by 2,161
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978 · cited 1×
“This situation of persistent antigen has been investigated using a number of chronic viral models (Zajac et al., 1998).”
BackgroundREGULATION OF IMMUNE RESPONSES BY TGF-β
Letterio, J. J., & Roberts, A. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.137 · Cited by 1,890
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Bretscher, P., & Cohn, M. (1970) · Science · doi:10.1126/science.169.3950.1042 · Cited by 1,692
Phan, G. Q., Yang, J. C., Sherry, R. M., Hwu, P., Topalian, S. L., Schwartzentruber, D. J., Restifo, N. P., Haworth, L. R., Seipp, C. A., Freezer, L. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533209100 · Cited by 1,575
Liyanage, U. K., Moore, T. T., Joo, H.-G., Tanaka, Y., Herrmann, V., Doherty, G., Drebin, J. A., Strasberg, S. M., Eberlein, T. J., Goedegebuure, P. S., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2756 · Cited by 1,467
CD4+CD25+ Immunoregulatory T Cells
McHugh, R. S., Whitters, M. J., Piccirillo, C. A., Young, D. A., Shevach, E. M., Collins, M., & Byrne, M. C. (2002) · Immunity · doi:10.1016/s1074-7613(02)00280-7 · Cited by 1,395
Role of LAG-3 in Regulatory T Cells
Huang, C.-T., Workman, C. J., Flies, D., Pan, X., Marson, A. L., Zhou, G., Hipkiss, E. L., Ravi, S., Kowalski, J., Levitsky, H. I., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.010 · Cited by 1,325
Self-citationBonifaz, L., Bonnyay, D., Mahnke, K., Rivera, M., Nussenzweig, M. C., & Steinman, R. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021598 · Cited by 1,306
Schwartz, R. H. (1992) · Cell · doi:10.1016/s0092-8674(05)80055-8 · Cited by 1,293 · cited 1×
“Originally, the relevant costimulatory signals were envisioned to be provided by B7 family costimulatory molecules expressed by DCs (Schwartz, 1992).”
BackgroundMunn, D. H., Sharma, M. D., Baban, B., Harding, H. P., Zhang, Y., Ron, D., & Mellor, A. L. (2005) · Immunity · doi:10.1016/j.immuni.2005.03.013 · Cited by 1,272
Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity
Chen, L. (2004) · Nature Reviews Immunology · doi:10.1038/nri1349 · Cited by 1,257
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
Niu, G., Wright, K. L., Huang, M., Song, L., Haura, E., Turkson, J., Zhang, S., Wang, T., Sinibaldi, D., Coppola, D., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205260 · Cited by 1,207 · cited 1×
“Constitutive activation of Stat3 in tumor cells has been shown to upregulate cell cycle regulatory, proangiogenic and antiapoptotic genes critical to the transformation process (Bowman et al., 2001; Bromberg et al., 1999; Niu et al., 2002; Turkson et al., 1998).”
BackgroundSelf-citationYee, C., Thompson, J. A., Byrd, D., Riddell, S. R., Roche, P., Celis, E., & Greenberg, P. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242600099 · Cited by 1,206
Marincola, F. M., Jaffee, E. M., Hicklin, D. J., & Ferrone, S. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60911-6 · Cited by 1,174
Self-citationRole of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
Huang, A. Y. C., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., & Levitsky, H. (1994) · Science · doi:10.1126/science.7513904 · Cited by 1,160
Self-citationRegulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
Wang, T., Niu, G., Kortylewski, M., Burdelya, L., Shain, K., Zhang, S., Bhattacharya, R., Gabrilovich, D., Heller, R., Coppola, D., et al. (2004) · Nature Medicine · doi:10.1038/nm976 · Cited by 1,155
Self-citationT-cell apoptosis detected in situ during positive and negative selection in the thymus
Surh, C. D., & Sprent, J. (1994) · Nature · doi:10.1038/372100a0 · Cited by 1,066
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
Kortylewski, M., Kujawski, M., Wang, T., Wei, S., Zhang, S., Pilon-Thomas, S., Niu, G., Kay, H., Mulé, J., Kerr, W. G., et al. (2005) · Nature Medicine · doi:10.1038/nm1325 · Cited by 1,031
Self-citationPotential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase
Munn, D. H., Sharma, M. D., Lee, J. R., Jhaver, K. G., Johnson, T. S., Keskin, D. B., Marshall, B., Chandler, P., Antonia, S. J., Burgess, R., et al. (2002) · Science · doi:10.1126/science.1073514 · Cited by 1,028
Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity
Hirano, F., Kaneko, K., Tamura, H., Dong, H., Wang, S., Ichikawa, M., Rietz, C., Flies, D. B., Lau, J. S., Zhu, G., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.1089.65.3 · Cited by 1,018
Schmielau, J., & Finn, O. J. (2001) · PubMed · Cited by 1,010
Mechanisms of suppression by suppressor T cells
von Boehmer, H. (2005) · Nature Immunology · doi:10.1038/ni1180 · Cited by 1,007
Anderson, P. C. (1999) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.281.24.2351 · Cited by 1,006
Chambers, C. A., Kuhns, M. S., Egen, J. G., & Allison, J. P. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.565 · Cited by 998
Gorelik, L., & Flavell, R. A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80170-3 · Cited by 962
T-cell receptor Vβ use predicts reactivity and tolerance to Mlsa- encoded antigens
MacDonald, H. R., Schneider, R., Lees, R. K., Howe, R. C., Acha-Orbea, H., Festenstein, H., Zinkernagel, R. M., & Hengartner, H. (1988) · Nature · doi:10.1038/332040a0 · Cited by 888
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
Watanabe, N., Gavrieli, M., Sedy, J. R., Yang, J., Fallarino, F., Loftin, S. K., Hurchla, M. A., Zimmerman, N., Sim, J., Zang, X., et al. (2003) · Nature Immunology · doi:10.1038/ni944 · Cited by 883 · cited 2×
“Murphy and colleagues, have recently described a new member of the coinhibitor group of molecules, which they coined BTLA (B and T lymphocyte attenuator) (Watanabe et al., 2003).”
BackgroundB7-Dc, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells
Tseng, S.-Y., Otsuji, M., Gorski, K., Huang, X., Slansky, J. E., Pai, S. I., Shalabi, A., Shin, T., Pardoll, D. M., & Tsuchiya, H. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.7.839 · Cited by 872
Self-citationMunn, D. H., Sharma, M. D., Hou, D., Baban, B., Lee, J. R., Antonia, S. J., Messina, J. L., Chandler, P., Koni, P. A., & Mellor, A. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21583 · Cited by 852 · cited 1×
“Apparently, the major IDO producing DC subset is either a plasmacytoid DC (PDC) or a PDC‐related cell that is B220þ (Munn et al., 2004).”
BackgroundZea, A. H., Rodriguez, P. C., Atkins, M. B., Hernandez, C., Signoretti, S., Zabaleta, J., McDermott, D., Quiceno, D., Youmans, A., O'Neill, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4505 · Cited by 851
Kusmartsev, S., Nefedova, Y., Yoder, D., & Gabrilovich, D. I. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.989 · Cited by 850
The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice
Ansari, M. J. I., Salama, A. D., Chitnis, T., Smith, R. N., Yagita, H., Akiba, H., Yamazaki, T., Azuma, M., Iwai, H., Khoury, S. J., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022125 · Cited by 814
Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo
Chen, M.-L., Pittet, M. J., Gorelik, L., Flavell, R. A., Weissleder, R., von Boehmer, H., & Khazaie, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408197102 · Cited by 806
Thompson, R. H., Gillett, M. D., Cheville, J. C., Lohse, C. M., Dong, H., Webster, W. S., Krejci, K. G., Lobo, J. R., Sengupta, S., Chen, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406351101 · Cited by 776
Ljunggren, H. G., & Kärre, K. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.6.1745 · Cited by 736
Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity
Pepper, M. S. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(96)00048-2 · Cited by 724
Induction of antigen-specific T cell anergy: An early event in the course of tumor progression
Staveley-O’Carroll, K., Sotomayor, E., Montgomery, J., Borrello, I., Hwang, L., Fein, S., Pardoll, D., & Levitsky, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1178 · Cited by 704
Self-citationClinical significance of defective dendritic cell differentiation in cancer.
Almand, B., Resser, J. R., Lindman, B. R., Nadaf, S., Clark, J. I., Kwon, E. D., Carbone, D. P., & Gabrilovich, D. I. (2000) · PubMed · Cited by 699
Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism
Mazzoni, A., Bronte, V., Visintin, A., Spitzer, J. H., Apolloni, E., Serafini, P., Zanovello, P., & Segal, D. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.689 · Cited by 690
Stat3 Activation by Src Induces Specific Gene Regulation and Is Required for Cell Transformation
Turkson, J., Bowman, T., Garcia, R., Caldenhoven, E., De Groot, R. P., & Jove, R. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2545 · Cited by 651
North, R. J. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.4.1063 · Cited by 650
Cancer vaccines: between the idea and the reality
Finn, O. J. (2003) · Nature Reviews Immunology · doi:10.1038/nri1150 · Cited by 636
Laping, N. J., Grygielko, E., Mathur, A., Butter, S., Bomberger, J., Tweed, C., Martin, W., Fornwald, J., Lehr, R., Harling, J., et al. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.58 · Cited by 635
Alterations in Signal Transduction Molecules in T Lymphocytes from Tumor-Bearing Mice
Mizoguchi, H., O'Shea, J. J., Longo, D. L., Loeffler, C. M., McVicar, D. W., & Ochoa, A. C. (1992) · Science · doi:10.1126/science.1465616 · Cited by 632
Sedy, J. R., Gavrieli, M., Potter, K. G., Hurchla, M. A., Lindsley, R. C., Hildner, K., Scheu, S., Pfeffer, K., Ware, C. F., Murphy, T. L., et al. (2005) · Nature Immunology · doi:10.1038/ni1144 · Cited by 632
Cui, W., Fowlis, D. J., Bryson, S., Duffie, E., Ireland, H., Balmain, A., & Akhurst, R. J. (1996) · Cell · doi:10.1016/s0092-8674(00)80127-0 · Cited by 628
Initiating Cellular Stress Responses
Bakkenist, C. J., & Kastan, M. B. (2004) · Cell · doi:10.1016/j.cell.2004.06.023 · Cited by 544 · cited 1×
“These are all highly chemically reactive molecules that can cause oxidative stress in adjacent tumor cells (Bakkenist and Kastan, 2004).”
BackgroundRestifo, N. P., Marincola, F. M., Kawakami, Y., Taubenberger, J., Yannelli, J. R., & Rosenberg, S. A. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.2.100 · Cited by 533
Bronte, V., Apolloni, E., Cabrelle, A., Ronca, R., Serafini, P., Zamboni, P., Restifo, N. P., & Zanovello, P. (2000) · Blood · doi:10.1182/blood.v96.12.3838 · Cited by 527
Serafini, P., Carbley, R., Noonan, K. A., Tan, G., Bronte, V., & Borrello, I. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0757 · Cited by 523
Sano, S., Itami, S., Takeda, K., Tarutani, M., Yamaguchi, Y., Miura, H., Yoshikawa, K., Akira, S., & Takeda, J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.17.4657 · Cited by 519
IL-4-Induced Arginase 1 Suppresses Alloreactive T Cells in Tumor-Bearing Mice
Bronte, V., Serafini, P., De Santo, C., Marigo, I., Tosello, V., Mazzoni, A., Segal, D. M., Staib, C., Lowel, M., Sutter, G., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.270 · Cited by 513
Salama, A. D., Chitnis, T., Imitola, J., Ansari, M. J. I., Akiba, H., Tushima, F., Azuma, M., Yagita, H., Sayegh, M. H., & Khoury, S. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022119 · Cited by 506
Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis
Bowman, T., Broome, M. A., Sinibaldi, D., Wharton, W., Pledger, W. J., Sedivy, J. M., Irby, R., Yeatman, T., Courtneidge, S. A., & Jove, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131568898 · Cited by 488
Ferrone, S., & Marincola, F. M. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80033-6 · Cited by 474
Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer
Nefedova, Y., Huang, M., Kusmartsev, S., Bhattacharya, R., Cheng, P., Salup, R., Jove, R., & Gabrilovich, D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.464 · Cited by 464
Frontline: Neuropilin‐1: a surface marker of regulatory T cells
Bruder, D., Probst‐Kepper, M., Westendorf, A. M., Geffers, R., Beissert, S., Loser, K., von Boehmer, H., Buer, J., & Hansen, W. (2004) · European Journal of Immunology · doi:10.1002/eji.200324799 · Cited by 453
Immune surveillance against a solid tumor fails because of immunological ignorance
Ochsenbein, A. F., Klenerman, P., Karrer, U., Ludewig, B., Pericin, M., Hengartner, H., & Zinkernagel, R. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2233 · Cited by 453
Machiels, J.-P., Reilly, R. T., Emens, L. A., Ercolini, A. M., Lei, R. Y., Weintraub, D., Okoye, F. I., & Jaffee, E. M. (2001) · PubMed · Cited by 453
Self-citationWallich, R., Bulbuc, N., Hämmerling, G. J., Katzav, S., Segal, S., & Feldman, M. (1985) · Nature · doi:10.1038/315301a0 · Cited by 402
Recruitment of latent pools of high-avidity CD8+ T cells to the antitumor immune response
Ercolini, A. M., Ladle, B. H., Manning, E. A., Pfannenstiel, L. W., Armstrong, T. D., Machiels, J.-P. H., Bieler, J. G., Emens, L. A., Reilly, R. T., & Jaffee, E. M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042167 · Cited by 399
Self-citationQuill, H., & Schwartz, R. H. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.11.3704 · Cited by 388
Doyle, A., Martin, W. J., Funa, K., Gazdar, A., Carney, D., Martin, S. E., Linnoila, I., Cuttitta, F., Mulshine, J., & Bunn, P. (1985) · The Journal of experimental medicine · doi:10.1084/jem.161.5.1135 · Cited by 382
Moretta, A., Biassoni, R., Bottino, C., Pende, D., Vitale, M., Poggi, A., Mingari, M. C., & Moretta, L. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00943.x · Cited by 350
Role Of Immature Myeloid Cells in Mechanisms of Immune Evasion In Cancer
Kusmartsev, S., & Gabrilovich, D. I. (2006) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-005-0048-z · Cited by 346
Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation
Hui, K., Grosveld, F., & Festenstein, H. (1984) · Nature · doi:10.1038/311750a0 · Cited by 341
Nefedova, Y., Nagaraj, S., Rosenbauer, A., Muro-Cacho, C., Sebti, S. M., & Gabrilovich, D. I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0529 · Cited by 318
D'Urso, C. M., Wang, Z. G., Cao, Y., Tatake, R., Zeff, R. A., & Ferrone, S. (1991) · Journal of Clinical Investigation · doi:10.1172/jci114984 · Cited by 309
Callahan, J. F., Burgess, J. L., Fornwald, J. A., Gaster, L. M., Harling, J. D., Harrington, F. P., Heer, J., Kwon, C., Lehr, R., Mathur, A., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010493y · Cited by 308
The Macrophage Growth Factor CSF-1 in Mammary Gland Development and Tumor Progression
Lin, E. Y., Gouon-Evans, V., Nguyen, A. V., & Pollard, J. W. (2002) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1020399802795 · Cited by 294
Adler, A. J., Marsh, D. W., Yochum, G. S., Guzzo, J. L., Nigam, A., Nelson, W. G., & Pardoll, D. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.10.1555 · Cited by 294
Self-citationMellor, A. L. (2004) · International Immunology · doi:10.1093/intimm/dxh140 · Cited by 288
Inhibitory MHC class I receptors on NK cells and T cells
Lanier, L. L., & Phillips, J. H. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80585-8 · Cited by 280
Koopman, L. A., Corver, W. E., van der Slik, A. R., Giphart, M. J., & Fleuren, G. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.6.961 · Cited by 279
Immunoregulatory T cells in tumor immunity
Terabe, M., & Berzofsky, J. A. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.01.010 · Cited by 264
Berd, D., Maguire, H. C., Jr., & Mastrangelo, M. J. (1986) · PubMed · Cited by 251
Uyttenhove, C., Maryanski, J., & Boon, T. (1983) · The Journal of experimental medicine · doi:10.1084/jem.157.3.1040 · Cited by 245
Hasegawa, Y., Takanashi, S., Kanehira, Y., Tsushima, T., Imai, T., & Okumura, K. (2001) · Cancer · doi:10.1002/1097-0142(20010301)91:5<964::aid-cncr1086>3.0.co;2-o · Cited by 244
Molecular Characterization of Defective Antigen Processing in Human Prostate Cancer
Sanda, M. G., Restifo, N. P., Walsh, J. C., Kawakami, Y., Nelson, W. G., Pardoll, D. M., & Simons, J. W. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.4.280 · Cited by 235
Self-citationTumour escape from immune surveillance through dendritic cell inactivation
Vicari, A. P., Caux, C., & Trinchieri, G. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0400 · Cited by 228
Ahmadzadeh, M., & Rosenberg, S. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5215 · Cited by 225
Shariat, S. F., Shalev, M., Menesses-Diaz, A., Kim, I. Y., Kattan, M. W., Wheeler, T. M., & Slawin, K. M. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.11.2856 · Cited by 214
Medema, J. P., Schuurhuis, D. H., Rea, D., van Tongeren, J., de Jong, J., Bres, S. A., Laban, S., Toes, R. E. M., Toebes, M., Schumacher, T. N. M., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.657 · Cited by 207
Maintenance of in Vivo Tolerance by Persistence of Antigen
Ramsdell, F., & Fowlkes, B. J. (1992) · Science · doi:10.1126/science.257.5073.1130 · Cited by 206
Rowe, M., Khanna, R., Jacob, C. A., Argaet, V., Kelly, A., Powis, S., Belich, M., Groom‐Carter, D., Lee, S., Burrows, S. R., et al. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250536 · Cited by 191
Hurchla, M. A., Sedy, J. R., Gavrielli, M., Drake, C. G., Murphy, T. L., & Murphy, K. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3377 · Cited by 181
Self-citationBaban, B., Hansen, A. M., Chandler, P. R., Manlapat, A., Bingaman, A., Kahler, D. J., Munn, D. H., & Mellor, A. L. (2005) · International Immunology · doi:10.1093/intimm/dxh271 · Cited by 178
Natali, P. G., Bigotti, A., Nicotra, M., Viora, M., Manfredi, D., & Ferrone, S. (1984) · PubMed · Cited by 169
Lucas, C., Bald, L. N., Fendly, B. M., Mora-Worms, M., Figari, I. S., Patzer, E. J., & Palladino, M. A. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.5.1415 · Cited by 164
Immune selection after antigen-specific immunotherapy of melanoma
Riker, A., Cormier, J., Panelli, M., Kammula, U., Wang, E., Abati, A., Fetsch, P., Lee, K.-H., Steinberg, S., Rosenberg, S., et al. (1999) · Surgery · doi:10.1016/s0039-6060(99)70143-1 · Cited by 164
Shin, T., Kennedy, G., Gorski, K., Tsuchiya, H., Koseki, H., Azuma, M., Yagita, H., Chen, L., Powell, J., Pardoll, D., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030242 · Cited by 159
Self-citationSchwartz, R. H., Mueller, D. L., Jenkins, M. K., & Quill, H. (1989) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1989.054.01.072 · Cited by 159
Halak, B. K., Maguire, H., & Lattime, E. C. (1999) · PubMed · Cited by 158
Saito, H., Tsujitani, S., Oka, S., Kondo, A., Ikeguchi, M., Maeta, M., & Kaibara, N. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991015)86:8<1455::aid-cncr11>3.0.co;2-l · Cited by 154
Turkson, J., Zhang, S., Mora, L. B., Burns, A., Sebti, S., & Jove, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502694200 · Cited by 151
Benitez, R., Godelaine, D., Lopez‐Nevot, M. A., Brasseur, F., Jimenez, P., Marchand, M., Oliva, M. R., van Baren, N., Cabrera, T., Andry, G., et al. (1998) · Tissue Antigens · doi:10.1111/j.1399-0039.1998.tb03082.x · Cited by 149
Selective changes in expression of HLA class I polymorphic determinants in human solid tumors.
Natali, P. G., Nicotra, M., Bigotti, A., Venturo, I., Marcenaro, L., Giacomini, P., & Russo, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6719 · Cited by 146
Zhang, Q., Yang, X., Pins, M., Javonovic, B., Kuzel, T., Kim, S.-J., Parijs, L. V., Greenberg, N. M., Liu, V., Guo, Y., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3169 · Cited by 146
Augmentation of the human immune response by cyclophosphamide.
Berd, D., Mastrangelo, M. J., Engstrom, P. F., Paul, A., & Maguire, H. (1982) · PubMed · Cited by 138
Cancer immunotherapy: breaking the barriers to harvest the crop
Pardoll, D. M., & Allison, J. P. (2004) · Nature Medicine · doi:10.1038/nm0904-887 · Cited by 135
Self-citationUrban, J. L., Burton, R. C., Holland, J. M., Kripke, M. L., & Schreiber, H. W. (1982) · The Journal of Experimental Medicine · doi:10.1084/jem.155.2.557 · Cited by 135
Tumor Growth Enhances Cross-Presentation Leading to Limited T Cell Activation without Tolerance
Nguyen, L. T., Elford, A. R., Murakami, K., Garza, K. M., Schoenberger, S. P., Odermatt, B., Speiser, D. E., & Ohashi, P. S. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20010032 · Cited by 128
Fingerprints of anergic T cells
Lechner, O., Lauber, J., Franzke, A., Sarukhan, A., von Boehmer, H., & Buer, J. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00160-9 · Cited by 126
High frequency of altered HLA class I phenotypes in invasive breast carcinomas
Cabrera, T., Fernandez, M. A., Sierra, À., Garrido, A., Herruzo, A., Escobedo, A., Fabra, À., & Garrido, F. (1996) · Human Immunology · doi:10.1016/0198-8859(96)00145-0 · Cited by 126
Regulatory/suppressor T cells in health and disease
Shevach, E. M. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20500 · Cited by 122
Multiple tumour-specific antigens expressed on a single tumour cell
Wortzel, R. D., Philipps, C., & Schreiber, H. W. (1983) · Nature · doi:10.1038/304165a0 · Cited by 119
Lind, M. H., Rozell, B., Wallin, R. P. A., van Hogerlinden, M., Ljunggren, H.-G., Toftgård, R., & Sur, I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307106101 · Cited by 113
High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas
Cabrera, T., Collado, A., Fernandez, M. A., Ferron, A., Sancho, J., Ruiz‐Cabello, F., & Garrido, F. (1998) · Tissue Antigens · doi:10.1111/j.1399-0039.1998.tb02274.x · Cited by 111
de Vries, T. J., Eleveld-Trancikova, D., Ruiter, D., & van Muijen, G. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.646 · Cited by 111
Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer
Clarke, B. A. (2002) · Molecular Pathology · doi:10.1136/mp.55.1.19 · Cited by 106
Mouse tumor rejection antigens P815A and P815B : Two epitopes carried by a single peptide
Lethé, B., den Eynde, B. J. V., Pel, A. V., Corradin, G., & Boon, T. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220916 · Cited by 99
Cormier, J. N., Abati, A. D., Fetsch, P. A., Hijazi, Y. M., Rosenberg, S. A., Marincola, F. M., & Topalian, S. L. (1998) · Journal of Immunotherapy · doi:10.1097/00002371-199801000-00003 · Cited by 95
CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid.
Hatachi, S., Iwai, Y., Kawano, S., Morinobu, S., Kobayashi, M., Koshiba, M., Saura, R., Kurosaka, M., Honjo, T., & Kumagai, S. (2003) · PubMed · Cited by 92
Seliger, B., Höhne, A., Knuth, A. K., Bernhard, H., Ehring, B., Tampé, R., & Huber, C. G. (1996) · PubMed · Cited by 91
Wang, Z., Cao, Y., Albino, A. P., Zeff, R. A., Houghton, A., & Ferrone, S. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116249 · Cited by 91
Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx
Esteban, F., Concha, Á., Huelin, C., Perez‐Ayala, M., Pedrinaci, S., Ruiz‐Cabello, F., & Garrido, F. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430316 · Cited by 90
Young, M. R., Petruzzelli, G. J., Kolesiak, K., Achille, N. J., Lathers, D. M. R., & Gabrilovich, D. I. (2001) · Human Immunology · doi:10.1016/s0198-8859(01)00222-1 · Cited by 84
Naive CD4+ T cells confer idiotype‐specific tumor resistance in the absence of antibodies
Bogen, B., Munthe, L. A., Sollien, A., Hofgaard, P. O., Omholt, H., Dagnaes, F., Dembić, Z., & Lauritzsen, G. F. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251114 · Cited by 81
The evolving crosstalk between co-stimulatory and co-inhibitory receptors: HVEM–BTLA
Croft, M. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.03.010 · Cited by 77
Lyman, M. A., Aung, S., Biggs, J., & Sherman, L. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6558 · Cited by 76
Immunological ignorance of solid tumors
Ochsenbein, A. F. (2005) · Springer Seminars in Immunopathology · doi:10.1007/s00281-004-0192-0 · Cited by 70
Clonal deletion of thymocytes as a tumor escape mechanism
Lauritzsen, G. F., Hofgaard, P. O., Schenck, K., & Bogen, B. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19981005)78:2<216::aid-ijc16>3.0.co;2-8 · Cited by 67
Blanchet, O., Bourge, J. F., Zinszner, H., Israël, A., Kourilsky, P., Dausset, J. B., Degos, L., & Paul, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3488 · Cited by 66
Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx
Esteban, F., Concha, Á., Delgado‐Rodríguez, M., Perez‐Ayala, M., Ruiz‐Cabello, F., & Garrido, F. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.437 · Cited by 61
Sumimoto, H., Hirata, K., Yamagata, S., Miyoshi, H., Miyagishi, M., Taira, K., & Kawakami, Y. (2005) · International Journal of Cancer · doi:10.1002/ijc.21286 · Cited by 61
Nigam, A., Yacavone, R. F., ZAHURAK, M. L., Johns, C. M., Pardoll, D. M., Piantadosi, S., Levitsky, H. I., & Nelson, W. G. (1998) · International Journal of Oncology · doi:10.3892/ijo.12.1.161 · Cited by 58
Self-citationThe Expression of Histocompatibility-related Leukocyte Antigens in the Pathway to Cervical Carcinoma
Hilders, C. G. J. M., Houbiers, J. G. A., Krul, E. J. T., & Fleuren, G. J. (1994) · American Journal of Clinical Pathology · doi:10.1093/ajcp/101.1.5 · Cited by 57
Schmid, P., Itin, P. H., & Rufli, T. (1995) · Carcinogenesis · doi:10.1093/carcin/16.7.1499 · Cited by 53
SPI-CI and SPI-6 cooperate in the protection from effector cell–mediated cytotoxicity
Bots, M. L., Kolfschoten, I., Bres-Vloemans, S. A., Rademaker, M., de Roo, G. M., Krüse, M., Franken, K. L. M. C., Hahne, M., Froelich, C. J., Melief, C. J. M., et al. (2004) · Blood · doi:10.1182/blood-2004-03-0791 · Cited by 51
HETEROGENEITY OF THE EXPRESSION OF CLASS I AND II HLA ANTIGENS IN HUMAN BREAST CARCINOMA
Pérez, M., Cabrera, T., López‐Nevot, M. Á., Gomez, M., Perán, F., Ruiz‐Cabello, F., & Garrido, F. (1986) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.1986.tb01108.x · Cited by 49
Stepwise immunologic selection of antigenic variants during tumor growth.
Urban, J. L., Kripke, M. L., & Schreiber, H. W. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.9.3036 · Cited by 45
den Boer, A. T., van Mierlo, G. J. D., Fransen, M. F., Melief, C. J. M., Offringa, R., & Toes, R. E. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6074 · Cited by 41
Association of Allele-Specific HLA Expression and Histopathologic Progression of Cervical Carcinoma
van Driel, W. J., Tjiong, M. Y., Hilders, C. G. J. M., Trimbos, B. J. B. M. Z., & Fleuren, G. J. (1996) · Gynecologic Oncology · doi:10.1006/gyno.1996.0186 · Cited by 37
Molecular analysis of MHC-class-I alterations in human tumor cell lines
Ruiz‐Cabello, F., Perez‐Ayala, M., Gomez, O., Redondo, M., Concha, Á., Cabrera, T., & Garrido, F. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910470723 · Cited by 27
Klein, S. C., Jücker, M., Abts, H. F., & Tesch, H. (1995) · Hematological Oncology · doi:10.1002/hon.2900130302 · Cited by 25
Egorov, I. K. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0007-8 · Cited by 18
Moog-Lutz (1997) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-0215(19970410)71:2
Cited by
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Self-citationZhang, Y., & Zhang, Z. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0488-6 · Cited by 2,794
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Havel, J. J., Chowell, D., & Chan, T. A. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0116-x · Cited by 2,286
Chiappinelli, K. B., Strissel, P. L., Desrichard, A., Li, H., Henke, C., Akman, B., Hein, A., Rote, N. S., Cope, L. M., Snyder, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.011 · Cited by 2,022
“We hypothesize the low group may represent an ‘‘immune evasion/immune editing’’ pattern (Drake et al., 2006; Schreiber et al., 2011) that Aza could reverse to sensitize patients to subsequent immune therapy (Li et al., 2014).”
Self-citationImmunosuppressive Strategies that are Mediated by Tumor Cells
Rabinovich, G. A., Gabrilovich, D., & Sotomayor, E. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141609 · Cited by 1,702
Metadata
- Authors
- Drake, C. G., Jaffee, E., & Pardoll, D. M.
- Venue
- Advances in Immunology
- Publisher
- Elsevier
- Published
- 2006
- Volume
- 90
- Pages
- 51-81
- ISSN
- 0065-2776 (ISSN-L)
- OpenAlex
- W2140111836
- Cited by
- 688
- References
- 158
- FWCI
- 63.14
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.